Extent of Myocardial Infarction and Reverse Remodeling Assessed by Cardiac Magnetic Resonance in Patients With and Without Right Bundle Branch Block Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy

American Journal of Cardiology

Volumn 99, Issue 4, 2007, Pages 563-567

  McCann, Gerald P ^a   Van Dockum, Willem G ^b   Beek, Aernout M ^b   Nijveldt, Robin ^b   Ten Cate, Folkert J ^c   Ten Berg, Jurrien M ^d   Van Rossum, Albert C ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREATINE KINASE;

ADULT; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE PRESSURE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; NUCLEAR MAGNETIC RESONANCE; PERCUTANEOUS ALCOHOL SEPTAL ABLATION; PRESSURE GRADIENT; PRIORITY JOURNAL;

BUNDLE-BRANCH BLOCK; CARDIOMYOPATHY, HYPERTROPHIC; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 33846833448     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.08.067     Document Type: Article

References (19)

1. Firoozi S., Elliott P.M., Sharma S., Murday A., Brecker S.J., Hamid M.S., Sachdev B., Thaman R., and McKenna W.J. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 23 (2002) 1617-1624
2. Chang S.M., Lakkis N.M., Franklin J., Spencer III W.H., and Nagueh S.F. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation 109 (2004) 824-827
3. Talreja D.R., Nishimura R.A., Edwards W.D., Valeti U.S., Ommen S.R., Tajik A.J., Dearani J.A., Schaff H.V., and Holmes J. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44 (2004) 2329-2332
4. Veselka J., and Honek T. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol 88 (2003) 27-32
5. Li Z.Q., Cheng T.O., Zhang W.W., Qiao S.B., Zhao L.Y., Jin Y.Z., Guan R.M., and Liu L. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: the Chinese experience in 119 patients from a single center. Int J Cardiol 93 (2004) 197-202
6. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., and Strick M.D. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 31 (1998) 252-258
7. Mazur W., Nagueh S.F., Lakkis N.M., Middleton K.J., Killip D., Roberts R., and Spencer III W.H. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 103 (2001) 1492-1496
8. Runquist L.H., Nielsen C.D., Killip D., Gazes P., and Spencer III W.H. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 90 (2002) 1020-1022
9. Qin J.X., Shiota T., Lever H.M., Asher C.R., Popovic Z.B., Greenberg N.L., Agler D.A., Drinko J.K., Smedira N.G., and Tuzcu E.M. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93 (2004) 171-175
10. Kazmierczak J., Kornacewicz-Jach Z., Kisly M., Gil R., and Wojtarowicz A. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Heart 80 (1998) 257-262
11. Chang S.M., Nagueh S.F., Spencer III W.H., and Lakkis N.M. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 42 (2003) 296-300
12. van Dockum W.G., ten Cate F.J., ten Berg J.M., Beek A.M., Twisk J.W.R., Vos J., Hofman M.B.M., Visser C.A., and van Rossum A.C. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 27-34
13. van Dockum W.G., Beek A.M., ten Cate F.J., ten Berg J.M., Bondarenko O., Gotte M.J.W., Twisk J.W.R., Hofman M.B.M., Visser C.A., and van Rossum A.C. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 (2005) 2503-2508
14. Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., Klocke F.J., Bonow R.O., and Judd R.M. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
15. Beek A.M., Kuhl H.P., Bondarenko O., Twisk J.W.R., Hofman M.B.M., van Dockum W.G., Visser C.A., and van Rossum A.C. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42 (2003) 895-901
16. Bondarenko O., Beek A.M., Hofman M.B.M., Kuhl H.P., Twisk J.W.R., van Dockum W.G., Visser C.A., and van Rossum A.C. Standardizing the definition of hyperenhancement in the quantitaive assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7 (2005) 481-485
17. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., and Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 1778-1785
18. van Dam R.T., Roos J.P., and Durrer D. Electrical activation of ventricles and interventricular septum in hypertrophic cardiomyopathy. Br Heart J 34 (1972) 100-112
19. Grothues F., Smith G.C., Moon J.C.C., Bellenger N.G., Collins P., Klein H.U., and Pennell D.J. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90 (2002) 29-34